RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • Empagliflozin as Add-on Therapy to Pioglitazone With or Without Metformin in Patients With Type 2 Diabetes Mellitus.

Empagliflozin as Add-on Therapy to Pioglitazone With or Without Metformin in Patients With Type 2 Diabetes Mellitus.

Add to Collection
2015 Aug Others CS Kovacs, V Seshiah, L Merker, AV Christiansen… - Clinical …, 2015 - Elsevier

Full Author : ['Kovacs, Christopher S', 'Seshiah, Veeraswamy', 'Merker, Ludwig', 'Christiansen, Anita Vedel', 'Roux, Flavien', 'Salsali, Afshin', 'Kim, Gabriel', 'Stella, Peter', 'Woerle, Hans-Juergen', 'Broedl, Uli C']
Journal Title : Clinical therapeutics
Chapter : Section3
Journal Year : 2015
Cited by : 100.0

PURPOSE: To investigate the long-term efficacy and safety of empagliflozin as add-on therapy to pioglitazone with or without metformin in patients with type 2 diabetes mellitus. METHODS: Of 498 patients randomized to empagliflozin 10 mg, empagliflozin 25 ..... Read More

Keywords : ["type diabetes mellitus", "without metformin", "addon therapy", "pioglitazone", "patient", "empagliflozin"]
PubMed Link : https://www.sciencedirect.com/science/article/pii/S014929181500853X
Google Scholar Link : https://scholar.google.com/scholar?cites=4166567496767844630&as_sdt=2005&sciodt=0,5&hl=en&num=20